The effects of biochars produced in different pyrolsis temperatures from agricultural wastes on cadmium uptake of tobacco plant

Abiotic stresses caused by cadmium (Cd) contamination in soil retard plant growth and decline the quality of food. Amendment of biochar was reported effective in reduction of mobility, plant uptake and toxicity of Cd in plants. The aim of this study was to investigate the effect of biochar applications produced from corn cob and rice husk at three different pyrolysis temperatures (400, 500 and 600 °C) on Cd uptake of tobacco plants. The results showed that the shoot Cd concentration and content of tobacco plants significantly increased with the application of Cd in increasing doses. The results showed that increasing Cd dosescaused significant increase (P < 0.01) in shoot Cd concentration and content of the tobacco plant at three different pyrolysis temperatures of both corn cob and rice husk biochars. The concentration of Cd was 0.48 mg kg^?1 in Cd0 dose of corn cob biochar produced at 500 °C and increased to 61.6 mg kg^?1 at Cd5, while Cd concentration increased to 72.3 mg kg^?1 with rice husk biochar. Despite the increase in Cd concentrations and content, shoot Cd concentrations and contents were significantly (P < 0.01) reduced with the treatments of corn cob and rice husk biochars produced at different pyrolysis temperatures. The Cd concentration at Cd5 dose in the absence of biochar addition was 90.5 mg kg^?1, while Cd concentration at Cd5 dose in 400, 500 and 600 °C treatments of corn cob biochar was reduced to 66.5, 61.6 and 67.3 mg kg^?1 respectively, and to 77.0, 72.3 and 70.2 mg kg^?1 in rice husk biochar. The results also revealed that corn cob biochar treatments were more effective in reducing Cd uptake of tobacco plants compared to rice husk biochar. Higher specific surface area of corncob biochar compared to rice husk biochar caused to the difference between two biochar sources on Cd uptake of tobacco plants.     

Focus: Allergic Diseases and Type II Immunity: Model of Walnut Allergy in CC027/GeniUnc Mice Recapitulates Key Features of Human Disease

Tree nut allergies affect 1% of the United States population, are often severe in nature and rarely outgrown. Despite the severity and prevalence, there are no FDA-approved treatments for tree nut allergy. Development of a therapeutic would be expedited by having a mouse model that mimics the human disease. We utilized the CC027/GeniUnc mouse strain, which was previously identified as an orally reactive model of peanut allergy, to develop a model of walnut allergy. Mice were sensitized with walnut and cholera toxin for 4 weeks and subsequently challenged by oral gavage. Blood samples were collected to measure serum IgE. Walnut-sensitized mice produced high levels of walnut-IgE and were cross-sensitized to pecan. Oral challenges with walnut resulted in severe anaphylaxis and accompanying allergic symptoms. Importantly, pecan challenges also led to severe allergic reactions, indicating cross-reactivity to pecan. Overall, this novel mouse model reproduces key characteristics of human walnut allergy, which provides a platform to develop novel therapies and better understand sensitization mechanisms.     

PI3K/AKT/mTOR pathway and autophagy regulator genes in paranasal squamous cell carcinoma metastasis

Molecular Biology Reports - Although there are many studies on the role of PI3K/AKT/mTOR pathway and autophagy genes in the mechanism of head and neck cancer formation and prognostic significance,...     

Isolation and Characterization of a Bacteriocin-Like Substance Produced by <Emphasis Type="Italic">Geobacillus toebii</Emphasis> Strain HBB-247

A total of 201 thermophilic bacteria isolated from various thermal spring, mud and soil were tested for their antibacterial activity. Among the mostly active isolates, Geobacillus toebii HBB-247 was further examined. Bacteriocin-like inhibitory substance (BLIS) produced by strain HBB-247 was found to be stable up to 60°C, sensitive to proteolytic enzymes and effective against Enterococcus faecalis, Listeria sp., E. avium, Clostridium pasteurianum, Cellulomonas fimi and some thermophilic strains isolated and identified in this study. As a result of Tricine-SDS-PAGE molecular weight of BLIS was estimated about 38 kDa. Production studies showed that G. toebii HBB-247 starts to produce antibacterial substance at early logarithmic phase of growth and maximum production was detected at the end of the logarithmic phase.     

Feasibility of allogeneic mesenchymal stem cells in pediatric hypoxic-ischemic encephalopathy: Phase I study

BACKGROUNDHypoxic-ischemic encephalopathy (HIE) is one of the leading causes of death and long-term neurological impairment in the pediatric population. Despite a limited number of treatments to cure HIE, stem cell therapies appear to be a potential treatment option for brain injury resulting from HIE.AIMTo investigate the efficacy and safety of stem cell-based therapies in pediatric patients with HIE.METHODSThe study inclusion criteria were determined as the presence of substantial deficit and disability caused by HIE. Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) were intrathecally (IT), intramuscularly (IM), and intravenously administered to participants at a dose of 1 × 10⁶/kg for each administration route twice monthly for 2 mo. In different follow-up durations, the effect of WJ-MSCs administration on HIE, the quality of life, prognosis of patients, and side effects were investigated, and patients were evaluated for neurological, cognitive functions, and spasticity using the Wee Functional Independence Measure (Wee FIM) Scale and Modified Ashworth (MA) Scale. RESULTSFor all participants (n = 6), the mean duration of exposure to hypoxia was 39.17 + 18.82 min, the mean time interval after HIE was 21.83 ± 26.60 mo, the mean baseline Wee FIM scale score was 13.5 ± 0.55, and the mean baseline MA scale score was 35 ± 9.08. Three patients developed only early complications such as low-grade fever, mild headache associated with IT injection, and muscle pain associated with IM injection, all of which were transient and disappeared within 24 h. The treatment was evaluated to be safe and effective as demonstrated by magnetic resonance imaging examinations, electroencephalographies, laboratory tests, and neurological and functional scores of patients. Patients exhibited significant improvements in all neurological functions through a 12-mo follow-up. The mean Wee FIM scale score of participants increased from 13.5 ± 0.55 to 15.17 ± 1.6 points (mean ± SD) at 1 mo (z = - 1.826, P = 0.068) and to 23.5 ± 3.39 points at 12 mo (z = -2.207, P = 0.027) post-treatment. The percentage of patients who achieved an excellent functional improvement (Wee FIM scale total score = 126) increased from 10.71% (at baseline) to 12.03% at 1 mo and to 18.65% at 12 mo post-treatment. CONCLUSIONBoth the triple-route and multiple WJ-MSC implantations were safe and effective in pediatric patients with HIE with significant neurological and functional improvements. The results of this study support conducting further randomized, placebo-controlled studies on this treatment in the pediatric population.